mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.067 |
0.7 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |